Optimi Health Corp. Common Shares (NAS: OPTH) Stock Analysis & Fundamentals

OPTHOptimi Health Corp. Common Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · optimihealth.ca

4.730USD-2.87%Mkt Cap: 27.08M $P/E: —2d ago

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap27.08M $

Enterprise Value13.00M $

Revenue (TTM)175.67K $

Gross Profit-68.13K $

Net Income (TTM)-3.71M $

Revenue/Share0.0500 USD

Last Price4.730 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.22

EV/Revenue73.98

P/S158.73

P/B6.18

EPS (TTM)-1.49

EPS (Forward)—

52W Range

4.00030% of range6.400

52W High6.400 USD

52W Low4.000 USD

Profitability

Gross Margin-15.98%

Oper. Margin-957.82%

EBITDA Margin0.00%

Profit Margin-870.75%

ROE-56.49%

ROA-24.40%

Growth

Revenue Growth-28.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.63M $

CapEx (TTM)88.38K $

FCF Margin-890.48%

FCF Yield-5.78%

Net Debt-7.93M $

Net Debt/EBITDA1.96

Balance Sheet

Debt/Equity0.99

Current Ratio1.73

Quick Ratio1.62

Book Value/Sh0.7876 USD

Cash/Share3.043 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.5.73M

Float3.49M

Insiders12.66%

Institutions7.75%

Short Interest

Short Ratio0.3d

Short % Out.0.36%

Shares Short72.20K

Short (prev mo.)66.00K

Technical

SMA 504.673 (+1.2%)

SMA 2004.869 (-2.9%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)171.28K

Avg Vol (10d)26.45K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—